Biotechnology News Round-up.

The article offers global news briefs related to pharmaceutical industry. A clinical trial conducted by researchers at the Washington School of Medicine has assessed the capability of the micro-array riboleukogram, based on gene chip technology, in detecting early indicators of immune responses to infection before clinical signs of disease occur. Celgene Corp. has closed its acquisition of Pharmion Corp. for $2.9 billion. PDL BioPharma Inc. plans to renew its focus on research and development.